# reload+after+2024-01-20 11:39:59.211707
address1§1100 Melville Street
address2§Suite 888
city§Vancouver
state§BC
zip§V6E 4A6
country§Canada
phone§604-669-0555
fax§604-669-0533
website§https://www.ondinebio.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Ondine Biomedical Inc., a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens. The company's lead product is Steriwave, a photodisinfection-based medical device that eliminates harmful nasal pathogens, which leads to healthcare-associated infections. Its product pipeline also includes development of a topical antiviral therapy for the upper respiratory tract that reduces viral titres and transmission of respiratory viruses, such as SARS-CoV-2, influenza, RSV, etc.; a solution for treatment of chronic rhinosinusitis; a solution for disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia; and a solution for decolonization of burns and wounds. The company was incorporated in 1996 and is headquartered in Vancouver, Canada.
companyOfficers§[{'maxAge': 1, 'name': 'Ms. Carolyn M. Cross C.F.A., CFA, M.B.A., MBA', 'title': 'Founder, CEO & Executive Director', 'fiscalYear': 2022, 'totalPay': 505166, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Nicolas G. Loebel Ph.D.', 'title': 'President, CTO & Executive Director', 'fiscalYear': 2022, 'totalPay': 590177, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Simon  Sinclair Ph.D.', 'age': 51, 'title': 'Chief Medical Officer & Director', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 73605, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Vipul  Shah', 'title': 'VP & CFO', 'fiscalYear': 2022, 'totalPay': 58126, 'exercisedValue': 0, 'unexercisedValue': 242661}, {'maxAge': 1, 'name': 'Angelika  Vance', 'title': 'Vice President of Corporate Communications', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Matt  Ross', 'title': 'Vice President of Sales & Marketing', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Nikita  Parkhaev', 'title': 'Company Secretary', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§-0.163
priceToSalesTrailing12Months§24.677832
currency§GBp
exchange§LSE
quoteType§EQUITY
shortName§ONDINE BIOMEDICAL INC. COM SHS 
longName§Ondine Biomedical Inc.
firstTradeDateEpochUtc§1638777600
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§ed813bdd-f3ff-3b5d-9479-422add9111fa
recommendationKey§none
quickRatio§1.711
grossMargins§0.49005002
ebitdaMargins§0.0
trailingPegRatio§None
